Nu Skin Enterprises (NYSE:NUS) Updates FY22 Earnings Guidance

Nu Skin Enterprises (NYSE:NUSGet Rating) issued an update on its FY22 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $3.60-3.90 for the period, compared to the consensus estimate of $4.21. The company issued revenue guidance of $2.51-2.62 billion, compared to the consensus revenue estimate of $2.70 billion.Nu Skin Enterprises also updated its Q2 guidance to $0.75-0.85 EPS.

Several research firms have issued reports on NUS. Zacks Investment Research raised Nu Skin Enterprises from a hold rating to a strong-buy rating and set a $57.00 price objective on the stock in a report on Tuesday, March 29th. DA Davidson raised their price target on Nu Skin Enterprises from $47.00 to $50.00 and gave the company a neutral rating in a report on Thursday, February 17th. StockNews.com raised Nu Skin Enterprises from a hold rating to a buy rating in a report on Thursday. Jefferies Financial Group raised their target price on shares of Nu Skin Enterprises from $61.00 to $75.00 in a research note on Thursday, February 17th. Finally, TheStreet lowered shares of Nu Skin Enterprises from a b rating to a c+ rating in a report on Friday, February 18th. Two analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of Buy and a consensus target price of $60.60.

Shares of NUS stock traded up $1.10 on Friday, reaching $44.48. The company had a trading volume of 714,360 shares, compared to its average volume of 816,088. The stock has a market cap of $2.22 billion, a PE ratio of 16.47 and a beta of 1.24. The company has a 50-day moving average of $46.92 and a 200-day moving average of $47.65. The company has a current ratio of 1.65, a quick ratio of 0.89 and a debt-to-equity ratio of 0.29. Nu Skin Enterprises has a 12 month low of $39.40 and a 12 month high of $62.70.

Nu Skin Enterprises (NYSE:NUSGet Rating) last issued its earnings results on Wednesday, May 4th. The company reported $0.76 EPS for the quarter, beating the consensus estimate of $0.72 by $0.04. The firm had revenue of $604.90 million during the quarter, compared to the consensus estimate of $579.70 million. Nu Skin Enterprises had a net margin of 5.28% and a return on equity of 22.12%. The business’s quarterly revenue was down 10.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.91 earnings per share. Sell-side analysts anticipate that Nu Skin Enterprises will post 3.75 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 8th. Shareholders of record on Friday, May 27th will be issued a dividend of $0.385 per share. The ex-dividend date is Thursday, May 26th. This represents a $1.54 annualized dividend and a yield of 3.46%. Nu Skin Enterprises’s dividend payout ratio is presently 57.04%.

In other Nu Skin Enterprises news, Director Andrew D. Lipman sold 1,000 shares of Nu Skin Enterprises stock in a transaction that occurred on Tuesday, February 22nd. The shares were sold at an average price of $53.27, for a total value of $53,270.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Ryan S. Napierski sold 25,000 shares of the stock in a transaction on Friday, February 25th. The stock was sold at an average price of $47.40, for a total transaction of $1,185,000.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 28,000 shares of company stock valued at $1,333,390. Insiders own 2.80% of the company’s stock.

Several hedge funds have recently bought and sold shares of NUS. The Manufacturers Life Insurance Company boosted its holdings in Nu Skin Enterprises by 423.3% during the fourth quarter. The Manufacturers Life Insurance Company now owns 430,185 shares of the company’s stock worth $21,832,000 after purchasing an additional 347,985 shares during the last quarter. Allianz Asset Management GmbH grew its holdings in shares of Nu Skin Enterprises by 42.8% in the 4th quarter. Allianz Asset Management GmbH now owns 225,878 shares of the company’s stock valued at $11,463,000 after acquiring an additional 67,710 shares in the last quarter. Deutsche Bank AG increased its position in shares of Nu Skin Enterprises by 147.7% in the fourth quarter. Deutsche Bank AG now owns 80,647 shares of the company’s stock valued at $4,093,000 after acquiring an additional 48,091 shares during the last quarter. Parametric Portfolio Associates LLC raised its holdings in Nu Skin Enterprises by 4.6% during the fourth quarter. Parametric Portfolio Associates LLC now owns 386,623 shares of the company’s stock worth $19,621,000 after acquiring an additional 17,073 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC acquired a new position in Nu Skin Enterprises during the fourth quarter valued at approximately $455,000. 93.79% of the stock is owned by institutional investors.

About Nu Skin Enterprises (Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

Featured Stories

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.